Connection
Yong-Chen Lu to Interleukin-15 Receptor alpha Subunit
This is a "connection" page, showing publications Yong-Chen Lu has written about Interleukin-15 Receptor alpha Subunit.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.241 |
|
|
|
-
Cron KR, Fang P, Pham O, Janes J, Brandenburg J, Lu W, Zhu J, Peterson B, Tribble S, Kehoe H, Makarova A, Iannello A, Chan J, Skoble J, He H, Rae C, Thanos CD, Udyavar AR. ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Ra and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. 2025 Oct 06; 16:721-740.
Score: 0.241